

[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
[ Thu, Apr 04th 2024
] - WOPRAI
Vijay Kumar Maintained (ABT) at Buy with Increased Target to $125 on, Apr 4th, 2024
Vijay Kumar of Evercore ISI Group, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $120 to $125 on, Apr 4th, 2024.
Vijay has made no other calls on ABT in the last 4 months.
There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Vijay's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Vijay
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $128 on, Wednesday, April 3rd, 2024
- Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $128 on, Wednesday, February 14th, 2024
- Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $141 on, Friday, January 26th, 2024
- Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $127 on, Thursday, January 25th, 2024
- Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $121 on, Wednesday, December 13th, 2023
Contributing Sources